Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Lactate dynamics in Parkinson's disease: striatal circuit vulnerability, biomarker potential, and therapeutic windows

Kong J, Yang Z, Wang Y, Liu L, Liu Y, Chen W.

Mol Med. 2026 Jul 6;32(1):134. doi: 10.1186/s10020-026-01551-z.

Continuous subcutaneous levodopa and foslevodopa infusion therapy for motor symptoms of Parkinson disease: A systematic review of observational studies

Ali A, Cheema WA, Shamoon M, Azam H, Yousuf D, Tanveer A, Asif W, Nisar F, Ghafoor LA, Talha M, Ali MA, Saleem U, Shabbir MA, Abdullah A, Sharma M.

Medicine (Baltimore). 2026 Jul 3;105(27):e49597. doi: 10.1097/MD.0000000000049597.

Bridging the global Parkinson's divide: Technology as a structural solution for equitable and brain health-integrated care

Bhidayasiri R, Schneider RB, Maetzler W, Espay AJ, Lim TT, Phoumindr A, Kumar H, Pilotto A, Bloem BR.

J Parkinsons Dis. 2026 Jul 7:1877718X261466810. doi: 10.1177/1877718X261466810. Online ahead of print.

Sex-specific gut microbiota and metabolite signatures in Parkinson's disease: implications for personalized therapeutics

Sharma SA, Patri M.

Metab Brain Dis. 2026 Jul 7;41(1):158. doi: 10.1007/s11011-026-01924-7.

Transthyretin at the crossroads of neurodegeneration: a silent guardian in Parkinson's disease

Dipa P, Aran KR.

Metab Brain Dis. 2026 Jul 7;41(1):157. doi: 10.1007/s11011-026-01907-8.

β-sitosterol and next-generation neuroprotection for multi-target strategies and the gut-brain axis in neurodegenerative diseases

Sivalingam AM.

J Steroid Biochem Mol Biol. 2026 Jul 7;264:107080. doi: 10.1016/j.jsbmb.2026.107080. Online ahead of print.

Ageing-driven gastrointestinal variability in Parkinson's disease: implications for oral levodopa pharmacokinetics and formulation design

Madny MA, Yadav KS.

Eur J Pharm Biopharm. 2026 Sep;226:115179. doi: 10.1016/j.ejpb.2026.115179. Epub 2026 Jul 9.

Biological sex differences in neurodegenerative diseases in Africa: a scoping review of evidence and research gaps

Njohjam MN, Ngoule MO, Niakam TF.

BMC Neurol. 2026 Jul 7. doi: 10.1186/s12883-026-05123-w. Online ahead of print.

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection

Yang M, Liang Z.

Front Immunol. 2026 Jun 23;17:1839620. doi: 10.3389/fimmu.2026.1839620. eCollection 2026.

Enhanced Gait Variability Index in Neurological and Geriatric Rehabilitation: A Scoping Review

Wang M, Karakkattil P.

NeuroRehabilitation. 2026 Sep;59(2):200-217. doi: 10.1177/10538135261465012. Epub 2026 Jul 8.

Phase Separation Drives Pathological Aggregation in Neurodegenerative Diseases: A 15-Year Bibliometric Landscape (2009-2024)

Zhang C, Chen S, Zhao H, Wang Y, Zhou L, Fan H, Sun Y.

Ann N Y Acad Sci. 2026 Jul;1561(1):e70311. doi: 10.1111/nyas.70311.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias